German start-up collaborates with Lilly on therapies for hearing loss
Seamless Therapeutics licenses programmable recombinases for targeted correction of gene mutations
Biotechnology
At Twogee Biotech, we work hand-in-hand with you to unlock the hidden value in your material. Through a detailed techno-economic analysis, we assess both the potential and the costs required to realize it. Our goal: to increase your profitability by turning underutilized resources into high-value ...
View start-up
Biotechnology
Enodia Therapeutics is a biotechnology company developing best-in-class small-molecule therapies that enable the degradation of disease-driving proteins at the point of synthesis before they have a damaging effect. The company’s platform combines a proteomics-informed understanding of the ...
View start-up
Biotechnology
ErVimmune is a French preclinical biotechnology company founded in October 2019 by Prof. Stéphane Depil, an onco-hematologist and researcher at the Centre Léon Bérard and Cancer Research Center of Lyon. A spin-off from the Centre Léon Bérard, ErVimmune specializes in developing next-generation ...
View start-up
© 1997-2026 LUMITOS AG, All rights reserved